These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7031100)

  • 1. Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. A controlled double-blind trial.
    Carulli N; Ponz de Leon M; Podda M; Zuin M; Strata A; Frigerio G; Digrisolo A
    J Clin Pharmacol; 1981 Oct; 21(10):436-42. PubMed ID: 7031100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O; von Bergmann K
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid.
    Erlinger S; Le Go A; Husson JM; Fevery J
    Hepatology; 1984; 4(2):308-14. PubMed ID: 6706305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.
    Polli EE; Bianchi PA; Conte D; Sironi L
    Digestion; 1981; 22(4):185-91. PubMed ID: 7030835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
    Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
    Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS; Salen G; Shefer S
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
    Roda E; Bazzoli F; Labate AM; Mazzella G; Roda A; Sama C; Festi D; Aldini R; Taroni F; Barbara L
    Hepatology; 1982; 2(6):804-10. PubMed ID: 7141392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
    Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
    Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile.
    Bazzoli F; Fromm H; Roda A; Tunuguntla AK; Roda E; Barbara L; Amin P
    Dig Dis Sci; 1985 Jul; 30(7):650-4. PubMed ID: 4006647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid and serum-lipids.
    Bateson MC; Iqbal J
    Lancet; 1979 Jul; 2(8134):151. PubMed ID: 88587
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dissolution of biliary calculi with CDCA and UDCA].
    Sugata F
    Nihon Rinsho; 1984 Jul; 42(7):1683-9. PubMed ID: 6387220
    [No Abstract]   [Full Text] [Related]  

  • 13. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
    Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral cholelitholysis--cheno versus urso: Japanese experience.
    Nakayama F
    Dig Dis Sci; 1980 Feb; 25(2):129-34. PubMed ID: 6986241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
    Maton PN; Murphy GM; Dowling RH
    Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstones.
    Fromm H
    J Clin Gastroenterol; 1988; 10 Suppl 2():S18-21. PubMed ID: 3062080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.